Fig. 6

The anti-tumor activity of 3025@ML via lipid metabolism. PI3K: phosphatidylinositol 3-kinase; AKT: protein kinase B; mTOR: mammalian target of rapamycin; PKM2: pyruvate kinase M2; FASN: fatty acid synthase
The anti-tumor activity of 3025@ML via lipid metabolism. PI3K: phosphatidylinositol 3-kinase; AKT: protein kinase B; mTOR: mammalian target of rapamycin; PKM2: pyruvate kinase M2; FASN: fatty acid synthase